Shervin Esfahani

Vice President Global Marketing And Communications at Rekor Recognition Systems

Shervin Esfahani has a diverse work experience spanning various roles and industries. Shervin is currently the Vice President of Global Marketing and Communications at Rekor, a position they have held since January 2023. Prior to this, they served as the Vice President of Marketing at Rekor from September 2021 to January 2023. From December 2020 to September 2021, they were the Vice President of Demand Generation at the same company.

Before joining Rekor, Shervin worked as an Advisory Board Member at MYOR from November 2020 to February 2022. Shervin also gained experience as a Strategic Product Marketing professional at Surescripts from September 2019 to September 2020.

Shervin's earlier experience includes a significant role as the Marketing Director at VAYA Pharma, Inc, where they led the global marketing department and successfully launched multiple medical food prescription products. Their accomplishments include generating over $25 million in sales revenue and achieving 100% revenue growth, leading to the company's first profitable year. Shervin served in this role from June 2015 to September 2019.

Prior to VAYA Pharma, Shervin worked as a Marketing Manager at Lupin Pharmaceuticals. During their tenure, they led digital marketing tactics for three brand drugs and one medical device and played a key role in developing the company's digital marketing strategic plan. Shervin held this position from July 2013 to May 2015.

Shervin's early career began at The National Institutes of Health, where they worked as a Technical IRTA Fellow from September 2009 to July 2012.

Shervin Esfahani pursued their higher education starting in 2005 at Loyola University Chicago, where they obtained a Bachelor of Science (BS) degree in Biology. Following this, from 2012 to 2014, they attended The Johns Hopkins University - Carey Business School, where they earned a Master of Business Administration (MBA) degree with a focus on Marketing.

Links

Previous companies

Surescripts logo
National Institutes of Health logo